Peroxisome biogenesis disorder 13A is a rare inherited condition that usually starts before birth or in early infancy. It can affect the brain, liver, hearing, vision, muscle tone, and growth, so babies may seem very floppy, feed poorly, or have seizures. Not everyone will have the same experience. Peroxisome biogenesis disorder 13A is lifelong, and severe forms can be life-threatening in infancy or childhood, while milder forms may be recognized later and can have a longer outlook. Treatment for Peroxisome biogenesis disorder 13A focuses on supportive care, such as help with feeding, seizure control, hearing and vision support, and close follow-up with specialists.
How many people live with Peroxisome biogenesis disorder 13a?
Reliable worldwide and U.S. estimates for how many people are living with peroxisome biogenesis disorder 13A are not available from major rare-disease sources (Orphanet, 2024; Genetic and Rare Diseases Information Center, 2024). It is considered an extremely rare inherited condition, but no direct published count is available for either the world or the United States.
Overview
Peroxisome biogenesis disorder 13aSymptoms
Peroxisome biogenesis disorder 13A usually shows severe signs early in life. Common features include very low muscle tone, feeding trouble, seizures, vision and hearing problems, delayed development, and liver disease; some babies also have unusual facial features.
Outlook and prognosis
Peroxisome biogenesis disorder 13a often causes serious, lifelong health problems that begin in infancy. Outlook depends on how strongly the brain, liver, hearing, and vision are affected. Many children need ongoing specialist care and daily support.
Causes and risk factors
Peroxisome biogenesis disorder 13a is caused by harmful changes in the PEX13 gene. It is usually inherited when both parents pass on a nonworking copy. Family history raises the chance, while lifestyle or environmental factors do not cause it.
Genetic influences
Genetics are central to Peroxisome biogenesis disorder 13a, because it is caused by disease-causing changes in a specific gene. Different genetic variants can affect how severe symptoms are and when they begin, even within the same family.
Diagnosis
Peroxisome biogenesis disorder 13a is usually diagnosed by recognizing its clinical features and confirming them with genetic tests. Blood tests and sometimes imaging may also support the diagnosis of Peroxisome biogenesis disorder 13a.
Treatment and drugs
Peroxisome biogenesis disorder 13A is treated with supportive, symptom-based care. This often includes seizure medicines, feeding support, physical and occupational therapy, and close checks of hearing, vision, and liver health.
Symptoms
Peroxisome biogenesis disorder 13a usually becomes noticeable very early in life and can affect several parts of the body at once. Families often first see problems with muscle tone, feeding, vision or hearing, and developmental progress. Signs vary from person to person and can change over time.
Many babies with Peroxisome biogenesis disorder 13a feel unusually floppy and may struggle to lift the head or move strongly. This can make feeding, rolling, sitting, and other motor milestones harder.
Weak sucking, trouble swallowing, or reflux can make meals long and tiring. Some children cough with feeds, spit up often, or gain weight more slowly than expected.
Peroxisome biogenesis disorder 13a often affects how quickly a child learns to sit, walk, talk, and interact. Some children need a high level of support for mobility, communication, and daily routines.
Some children do not react to voices, soft sounds, or music the way families expect. Hearing loss can make language development harder unless it is picked up and supported early.
How people usually first notice Peroxisome biogenesis disorder 13a?
Peroxisome biogenesis disorder 13A is usually first noticed very early, often in infancy, when families or doctors see severe low muscle tone, feeding trouble, poor growth, and delays in reaching early milestones like holding up the head or rolling. The first signs of peroxisome biogenesis disorder 13A can also include hearing or vision problems, seizures, and distinctive findings on an exam such as liver enlargement or unusual facial features, although the exact pattern can vary from child to child. In some cases, concerns begin after abnormal newborn or early blood tests suggest a problem with how the body handles certain fats, which then leads to genetic testing to confirm the diagnosis.
Types of Peroxisome biogenesis disorder 13a
No distinct types of Peroxisome biogenesis disorder 13a are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or current medicines can meaningfully delay the start of symptoms in peroxisome biogenesis disorder 13a. This is an inherited condition that begins before birth, so symptoms often appear very early in life, and care is aimed at finding and treating problems such as feeding, hearing, vision, liver, and development issues as early as possible rather than preventing them from starting. Research into new treatments is ongoing, and staying closely connected with a specialist care team may help families get early support and learn about new options, even though it cannot promise a delay in symptoms.
What genetics can tell you about symptoms
In peroxisome biogenesis disorder 13A, changes in the PEX13 gene can help explain why some people have symptoms that start in infancy and are severe, while others have a milder course with later onset. Genetics can give clues about which body systems may be affected, such as the brain, liver, hearing, vision, and muscle tone, but it usually cannot predict the exact symptom pattern for one individual. Even among people with changes in the same gene, symptoms and severity can vary, so genetic results are most helpful when they are considered alongside exams, lab tests, and imaging.
Causes and risk factors
Peroxisome biogenesis disorder 13A is caused by harmful changes in both copies of the PEX13 gene. It is usually inherited from two parents who each carry one changed copy and often have no symptoms. The main risk factors for peroxisome biogenesis disorder 13A are family history and parents who are blood relatives. Some risks are written in our DNA, passed down through families. Lifestyle, diet, and common environmental exposures do not cause this condition, though other health problems can affect how severe symptoms are.
What are the most common causes or risk factors?
Peroxisome biogenesis disorder 13A is almost always caused by changes in a gene called PEX13, which helps the body build tiny parts of cells that break down certain fats and other substances. The main risk factor is family history: a child usually develops it only if both parents carry one changed copy of the gene and both pass it on, even though the parents are often healthy themselves. There are no known lifestyle or environmental causes, but the chance can be higher when parents are related to each other because they are more likely to carry the same rare gene change.
Environmental and biological risk factors
With peroxisome biogenesis disorder 13a, experts have not identified clear environmental exposures or other body-based factors that reliably raise the chance that it occurs. Awareness of both biological and environmental influences helps you feel prepared, but for this condition, current evidence does not point to pregnancy exposures, maternal illness, or birth events as clear causes. Most cases appear to begin very early in development rather than from something a parent did or did not do.
Genetic risk factors
Families often want to know why this rare condition happened and whether it could happen again. Peroxisome biogenesis disorder 13A is caused by harmful changes in a gene called PEX13, which helps cells build and run peroxisomes, tiny structures that process certain fats and chemicals. It is usually inherited, so the main risks relate to family genetics. In some cases, genetic testing can give a clearer picture of your personal risk.
PEX13 changes: Peroxisome biogenesis disorder 13A happens when both copies of the PEX13 gene have disease-causing changes. When PEX13 does not work properly, cells cannot form or use peroxisomes the way they should.
Recessive inheritance: This condition usually follows an autosomal recessive pattern, which means a child inherits one altered PEX13 copy from each parent. Parents with just one altered copy are usually healthy carriers.
Carrier parents: When both parents are carriers, each pregnancy has a 25% chance of resulting in a child with peroxisome biogenesis disorder 13A. There is also a 50% chance of having a child who is a healthy carrier and a 25% chance of having a child with no altered copies.
Family history: A known family history of PEX13-related disease or carrier status raises the chance that close relatives may also carry the same gene change. This is an important part of understanding the genetic causes of peroxisome biogenesis disorder 13A.
Related parents: Parents who are biologically related, such as cousins, are more likely to carry the same rare recessive gene change. That can increase the chance of peroxisome biogenesis disorder 13A in a child.
Lifestyle risk factors
Peroxisome biogenesis disorder 13A is an inherited condition, so lifestyle habits do not cause it. However, how lifestyle affects Peroxisome biogenesis disorder 13A can matter for day-to-day function, symptom control, and the risk of complications, especially when neurologic, liver, feeding, vision, or hearing problems are present. Because this disorder is rare and severity varies widely, the most useful lifestyle changes are usually individualized with the care team.
Poor intake, long fasting, or unbalanced nutrition can worsen low energy, poor growth, and feeding difficulties in people with Peroxisome biogenesis disorder 13A. A structured eating plan with adequate calories, protein, and fluids may help maintain strength and reduce stress during illness.
Too little movement can increase deconditioning, joint stiffness, constipation, and loss of motor skills when hypotonia or neurologic impairment is present. Regular, adapted activity and physical therapy can help preserve mobility, endurance, and participation while avoiding overexertion.
Irregular or poor-quality sleep can aggravate irritability, seizures, attention problems, and daytime fatigue in children or adults with neurologic symptoms. Consistent sleep habits may improve daily functioning and make other symptoms easier to manage.
Missed vaccines, poor hand hygiene, and delayed treatment of common infections can lead to bigger setbacks in a medically fragile person with Peroxisome biogenesis disorder 13A. Preventing dehydration and seeking prompt care during fever, vomiting, or breathing symptoms may reduce complications and recovery time.
Risk prevention
For peroxisome biogenesis disorder 13A, there is no proven way to prevent the condition itself because it is a genetic disorder present from birth. Prevention usually means lowering the chance of complications, catching problems early, and supporting day-to-day health as steadily as possible. Different people need different prevention strategies—there’s no single formula. For many living with peroxisome biogenesis disorder 13A, this can mean a mix of regular monitoring, infection prevention, safe feeding, and therapy support.
If this condition runs in your family, genetic counseling can help clarify the chance of having an affected child. Carrier testing and pregnancy testing may be options for some families planning a pregnancy.
Ongoing care can help spot treatable problems early, including some early symptoms of peroxisome biogenesis disorder 13A and later complications. Follow-up often includes growth, hearing, vision, liver, and nervous system checks.
People with peroxisome biogenesis disorder 13A may become sicker more quickly during common infections. Vaccines, hand hygiene, and early treatment of fevers or breathing symptoms can help lower this risk.
Feeding problems and reflux can raise the risk of poor growth or food going into the airway. A feeding plan, swallowing support, and watching for coughing or choking during meals may help prevent complications.
Can you prevent Peroxisome biogenesis disorder 13a?
No, peroxisome biogenesis disorder 13a cannot usually be prevented because it is caused by an inherited change in a gene and starts before birth. There is no known diet, medicine, or lifestyle change that can stop it from happening. If this condition runs in your family, genetic counseling and carrier testing may help you understand the chances in a future pregnancy and talk through family-building options.
Transmission
Peroxisome biogenesis disorder 13a is not infectious, so it cannot spread from one person to another through coughing, touch, food, sex, or everyday contact. For families wondering how Peroxisome biogenesis disorder 13a is inherited, it is usually passed down in an autosomal recessive pattern, which means a child has to inherit a changed copy of the related gene from both parents.
Parents are often healthy carriers and may have no symptoms themselves. When both parents are carriers, each pregnancy has a 1 in 4 chance of Peroxisome biogenesis disorder 13a, a 1 in 2 chance that the child will be a carrier, and a 1 in 4 chance that the child will inherit neither changed copy.
When to test your genes
Consider genetic testing if a baby or child has developmental delay, low muscle tone, seizures, hearing or vision problems, or liver concerns that suggest a peroxisomal disorder, especially with a family history. Testing confirms the diagnosis, guides supportive care, and helps with recurrence risk and family planning.
Diagnosis
Peroxisome biogenesis disorder 13a is usually suspected when a baby or child has a pattern of developmental, muscle, hearing, vision, or liver-related problems that seem to fit together rather than pointing to one common illness. Diagnosis often starts with the child’s medical history, physical exam, and a close look at features that can suggest this rare inherited condition. Getting a diagnosis is often a turning point toward answers and support. The genetic diagnosis of peroxisome biogenesis disorder 13a is then confirmed with specialized lab testing and genetic tests.
Doctors look for a combination of signs such as low muscle tone, feeding difficulties, delayed development, hearing or vision problems, and sometimes liver involvement. No single feature proves the condition, but the overall pattern can strongly raise suspicion.
A detailed pregnancy, birth, and developmental history can help show when symptoms began and how they have changed over time. Family history is also important because this condition is inherited and may be more likely if relatives have had similar unexplained problems.
Specialized blood tests can measure substances that build up when peroxisomes do not work properly, including very long-chain fatty acids. These results can support the diagnosis of peroxisome biogenesis disorder 13a and help separate it from other metabolic disorders.
Genetic tests look for disease-causing changes in the PEX13 gene, which is linked to peroxisome biogenesis disorder 13a. Finding changes in both copies of this gene usually confirms the diagnosis.
How is Peroxisome biogenesis disorder 13a diagnosed?
Doctors usually diagnose peroxisome biogenesis disorder 13A by putting together a child’s symptoms and exam findings with blood tests that show the body is not breaking down certain fats and related chemicals in the usual way. They may also use urine tests and checks of the eyes, hearing, brain, and liver to see which parts of the body are affected. A genetic test can then help confirm the diagnosis by finding the gene change linked to this condition.
Stages of Peroxisome biogenesis disorder 13a
Peroxisome biogenesis disorder 13a does not have defined progression stages. This is because it is a genetic condition with a wide range of symptoms from early life, rather than an illness that moves through clear step-by-step phases over time. Doctors usually start with a conversation about the early symptoms of Peroxisome biogenesis disorder 13a, along with an exam and tests that look at growth, development, hearing, vision, liver health, and brain function. Diagnosis is usually confirmed with specialized lab testing and genetic testing, and follow-up focuses on tracking day-to-day symptoms and checking for complications as a child grows.
Outlook and prognosis
The outlook for people with peroxisome biogenesis disorder 13A is highly variable, depending on how severely the nervous system, liver, hearing, and vision are affected. Individuals with severe early-onset disease can have major developmental impairment and may face life-threatening complications in infancy or childhood, while those with milder forms may survive into adolescence or adulthood. Prognosis is generally shaped by the degree of hypotonia, seizures, feeding difficulties, progressive hearing or vision loss, and liver dysfunction. The condition is typically chronic and noncurable, so long-term care focuses on symptom management, nutrition, developmental support, and monitoring for complications. Because published case numbers are very small, precise life-expectancy estimates are not available, but mortality is higher in the most severely affected children. Early multidisciplinary care can improve comfort, function, and quality of life, even though it does not change the underlying genetic disorder.
Long-term effects
Peroxisome biogenesis disorder 13A can affect many parts of the body over time, and the long-term picture depends a lot on how severe the condition is. Some children have very serious medical problems early in life, while others live longer with ongoing developmental and organ-related health effects. Long-term effects vary widely, even among people with closely related forms of this disorder.
Many living with peroxisome biogenesis disorder 13A have lasting delays in movement, speech, and learning. For some, this means needing lifelong help with communication, mobility, and daily care.
Low muscle tone early on can later affect posture, balance, and coordinated movement. Some people develop stiffness or trouble walking as they get older, which can make transfers and everyday activities harder.
Hearing problems are common and may become more noticeable as language and learning demands increase. In some children, reduced hearing adds to delays in speech and social development.
Eyesight may be affected by retinal disease, cataracts, or other eye problems linked to the condition. Families may first notice reduced tracking or poor night vision, and vision can continue to limit learning and independence over time.
How is it to live with Peroxisome biogenesis disorder 13a?
Living with peroxisome biogenesis disorder 13A can look very different from one person to another, but for many it means ongoing medical needs from infancy or childhood, often involving low muscle tone, feeding difficulties, hearing or vision problems, developmental delays, and sometimes liver or seizure-related care. Daily life may include frequent appointments, therapies, medications, nutrition support, and extra help with communication, movement, or learning, while some people with milder forms may be more active but still tire easily or need close follow-up. For families and other loved ones, the condition often brings both practical demands and emotional strain, since caregiving can be intensive and routines may need to revolve around medical equipment, safety, and specialized support.
Treatment and drugs
Peroxisome biogenesis disorder 13a is usually treated with supportive care, because there is no single medicine that can fix the underlying genetic change. Treatment often looks different for each person, but it commonly focuses on day-to-day needs such as feeding support, physical and occupational therapy, seizure treatment if needed, and careful monitoring of hearing, vision, liver health, and development. For many living with peroxisome biogenesis disorder 13a, this can mean working with several specialists to help with symptoms and to prevent complications as much as possible. Because early symptoms of peroxisome biogenesis disorder 13a and later health needs can vary, care plans are adjusted over time to match how the condition affects the child or adult.
Can you cure Peroxisome biogenesis disorder 13a?
No, there is currently no cure for peroxisome biogenesis disorder 13a. Treatment focuses on managing the problems it causes, such as feeding issues, seizures, hearing or vision loss, and delays in growth and development, and on giving supportive care to improve comfort and quality of life. Because this condition can affect people differently, care is usually tailored to each person's needs.
Non-drug treatment
Day-to-day care for people with Peroxisome biogenesis disorder 13a usually centers on supportive therapies that help with movement, feeding, communication, comfort, and development. Because this condition can affect many parts of the body, non-drug treatment is often tailored to a child’s symptoms and may change over time. Non-drug treatments often lay the foundation for daily care at home, in therapy, and at school. For many families, supportive care for Peroxisome biogenesis disorder 13a means building a team around the child’s changing needs.
Physical therapy can help with muscle stiffness or low muscle tone, joint range, and basic movement skills like rolling, sitting, or standing with support. It may also help prevent contractures and make daily positioning safer and more comfortable.
Occupational therapy focuses on hand use, play, seating, and everyday activities such as dressing, bathing, and using adaptive equipment. For many, this can mean finding simpler ways to support comfort, participation, and independence as much as possible.
Speech and language therapy can support communication, even when spoken language is limited. Therapists may also suggest nonverbal tools, such as picture systems or communication devices, to help children express needs and connect with others.
Feeding therapy can help with sucking, chewing, swallowing, and safer mealtimes if eating is tiring or leads to coughing or choking. Some may also need guidance on food texture, positioning during meals, or tube-feeding support when growth and nutrition are hard to maintain by mouth.
Your genes may have an impact on how drugs work for you
For people living with peroxisome biogenesis disorder 13a, there is no well-established proof that the gene change itself predictably changes how common medicines work in the body. In everyday care, medicine effects are more often shaped by the health problems that can come with this condition, such as liver problems, seizures, feeding issues, or overall frailty, so some may need lower doses, slower dose changes, or closer watching for side effects. This means treatment is usually individualized, with the care team choosing and adjusting medicines based on symptoms and how the person responds rather than on a known gene-based drug rule.
Pharmacological treatments
For many living with peroxisome biogenesis disorder 13a, there is no single medicine that corrects the underlying condition, so treatment usually focuses on day-to-day symptoms and organ problems. Drugs that target symptoms directly are called symptomatic treatments. The exact medicines depend on issues such as seizures, liver disease, muscle stiffness, reflux, or adrenal problems. Because this is a rare disorder, the medicines used for peroxisome biogenesis disorder 13a are tailored to each person and may change over time.
Anti-seizure drugs such as levetiracetam, valproic acid, clobazam, or topiramate may be used if seizures are part of peroxisome biogenesis disorder 13a. The best choice depends on seizure type, age, liver function, and side effects.
Cholic acid may be prescribed for some people with liver involvement related to peroxisomal disease. It can help improve bile flow and may lower the buildup of abnormal bile acid byproducts, although it is not right for everyone.
If testing shows adrenal insufficiency, hydrocortisone is commonly used to replace cortisol, and some people also need fludrocortisone. This treatment can help with low energy, poor stress tolerance, low blood pressure, or salt loss.
Medicines such as omeprazole or lansoprazole may help with acid reflux, feeding discomfort, or vomiting. For some families, taking medicine daily becomes as routine as other parts of feeding care, especially when stomach symptoms are frequent.
Genetic influences
Peroxisome biogenesis disorder 13a has a confirmed genetic cause: it happens when both copies of the PEX13 gene have disease-causing changes. PEX13 helps cells build and operate peroxisomes, which are small structures that break down certain fats and help manage harmful chemical byproducts, so when this gene is not working properly, many parts of the body can be affected. Peroxisome biogenesis disorder 13a is inherited in an autosomal recessive pattern, meaning a child must inherit one altered copy of PEX13 from each parent. A carrier means someone has one changed copy of the gene and usually no symptoms, so parents often do not know they carry it until a child is diagnosed. Even with the same condition, severity can vary from one child to another, in part because different PEX13 changes can leave different amounts of peroxisome function in place.
Is Peroxisome biogenesis disorder 13a genetic?
Genetics are central to Peroxisome biogenesis disorder 13a, because it is caused by disease-causing changes in a specific gene. Different genetic variants can affect how severe symptoms are and when they begin, even within the same family.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of being human and are widely seen in the general population. Most of these changes do not directly affect health and are simply part of natural human variation. For many genes, having a change connected to a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-understood change in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Peroxisome biogenesis disorder 13a, treatment is shaped by the exact genetic change because that change can affect how severely the brain, liver, hearing, vision, and muscles are involved. In practice, this means there is not usually one medicine that treats the root cause of Peroxisome biogenesis disorder 13a; instead, doctors build care around the symptoms a child or adult has, such as seizures, feeding problems, or movement difficulties. Not every difference in response is genetic, but genetic test results can help the care team confirm the diagnosis, understand which problems are more likely to develop, and decide how closely to monitor certain organs. This is especially helpful when thinking about the early symptoms of Peroxisome biogenesis disorder 13a and planning treatment over time. Some may find that medicines need to be adjusted carefully if the condition has also affected the liver or other organs that help the body handle drugs. At this time, treatment is mostly supportive rather than gene-targeted, but the genetic diagnosis can still guide choices, help families understand what to expect, and identify whether research studies may be an option.
Interactions with other conditions
People living with Peroxisome biogenesis disorder 13a often have medical problems that affect several body systems at once, so symptoms can overlap with liver disease, hearing loss, vision problems, and seizure disorders. In day-to-day life, a chest infection or stomach illness may lead to poorer feeding, more sleepiness, or less seizure control, making the underlying condition feel harder to manage. Doctors call it a “comorbidity” when two conditions occur together, and in Peroxisome biogenesis disorder 13a this can matter because liver strain, low muscle tone, and developmental problems may make recovery from other illnesses slower. The early symptoms of Peroxisome biogenesis disorder 13a can also resemble those of other metabolic or neurologic conditions, so careful evaluation is important when new symptoms appear. For many, this can mean several specialists need to coordinate care, especially if there are seizures, feeding difficulties, or breathing problems. Interactions can look very different from person to person, but new weakness, vomiting, jaundice, or a clear change from usual behavior should prompt medical review.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Peroxisome biogenesis disorder 13a?
Because peroxisome biogenesis disorder 13a can cause low muscle tone, feeding trouble, seizures, hearing or vision problems, and delayed development, it can look a lot like other Zellweger spectrum disorders and other rare inherited conditions that affect how the body breaks down certain fats. Doctors may also need to rule out mitochondrial diseases, which affect how cells make energy, as well as some other inherited metabolic disorders and early brain conditions that can also cause developmental delay and liver problems. Blood tests, brain scans, hearing and eye checks, and genetic testing are often needed to tell these conditions apart.
History
For families, the first signs are often what shape the story: a baby who is very floppy, has trouble feeding, or is not meeting early milestones. Long before today’s testing existed, doctors recognized that some infants and children had this pattern of serious developmental and body-wide health problems, even if they did not yet understand the cause. Early reports grouped these children by what could be seen at the bedside, especially differences in muscle tone, growth, hearing, vision, and liver function.
As medical science evolved, researchers began to see that these conditions were connected by a problem deep inside the body’s cells. Peroxisome biogenesis disorder 13A became part of a broader family of conditions linked to peroxisomes, which are tiny cell structures that help break down certain fats and support normal development. This shift mattered because it moved care beyond description alone and toward clearer diagnosis, helping doctors explain why symptoms could affect several organs at once.
Over time, laboratory testing made the picture sharper. Blood and tissue studies showed characteristic chemical changes, and later research confirmed that this disorder has a genetic cause. Not every early description was complete, yet together they built the foundation of today’s knowledge, including a better understanding that people living with peroxisome biogenesis disorder 13A can be affected in different ways, from severe problems early in life to less obvious features in some cases.
Today, the history of peroxisome biogenesis disorder 13A is still being written, largely because it is so rare. Better newborn and childhood evaluation, improved metabolic testing, and broader access to genetic testing have all helped more families get answers. That is especially important when early symptoms of peroxisome biogenesis disorder 13A may overlap with other conditions at first, making diagnosis challenging without specialized testing.